AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1431767
Drug: Particles-in-tablet form
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Particles-in-tablet form of erythromycin (333 mg three times daily for 10 days)
Trial: 1431767
Drug: Erythromycin ethylsuccinate
RxNorm normalized name: Erythromycin Ethylsuccinate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin ethylsuccinate (400 mg four times daily for 10 days)
Trial: 20299634
Drug: Antibiotic pretreatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic pretreatment
Trial: 27424011
Drug: Liquefied ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Liquefied ibuprofen 400 mg
Trial: 22947225
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (500 mg DHA + 150 mg EPA, 400 μg 5-methyltetrahydrofolate)
Trial: 20827544
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (cannulated screw fixation with postoperative splint immobilization for a maximum of 1 week)
Trial: 29471679
Drug: 70 mg
RxNorm normalized name: silybin 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg erenumab
Trial: 25491514
Drug: Dental health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental health education by qualified dentists and school teachers with supply of oral hygiene aids
Trial: 25491514
Drug: Dental health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental health education by qualified dentists and school teachers without supply of oral hygiene aids
Trial: 17469045
Drug: Pravastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (40 mg) for two weeks
Trial: 12433510
Drug: Subcutaneous melagatran
RxNorm normalized name: melagatran
DrugBank: Melagatran (DB13616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous melagatran followed by oral ximelagatran (dose categories: 1.00 mg, 1.50 mg, 2.25 mg, or 3.00 mg twice daily; followed by 8 mg, 12 mg, 18 mg, or 24 mg twice daily)
Trial: 12433510
Drug: Subcutaneous dalteparin
RxNorm normalized name: dalteparin
DrugBank: Dalteparin (DB06779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous dalteparin 5000 IU once daily
Trial: 9818340
Drug: Oral acetazolamide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral acetazolamide, 500 mg 1 hour preoperatively
Trial: 9818340
Drug: Oral acetazolamide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral acetazolamide, 500 mg immediately postoperatively
Trial: 7851351
Drug: Fentanyl (induction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (induction 10 micrograms kg‐1 plus infusion 10 micrograms kg‐1 h‐1)
Trial: 4164930
Drug: Indomethacin (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (doses above 150 mg per day)
Trial: 28950430
Drug: ADA +
RxNorm normalized name: Adenosine deaminase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADA + MTX combination therapy
Trial: 28298244
Drug: Manual administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual administration of anesthetics guided by BIS sensor
Trial: 28298244
Drug: Automated administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Automated administration of anesthetics
Trial: 12869078
Drug: Tioguanine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tioguanine (40 mg tablet preparation)
Trial: 8678493
Drug: Endocrine therapies
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapies
Trial: 29402141
Drug: Tirasemtiv (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirasemtiv (various doses)
Trial: 24535455
Drug: Rikkunshito (RKT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rikkunshito (RKT) + rabeprazole (10 mg/day) for 8 weeks
Trial: 24535455
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + rabeprazole (10 mg/day) for 8 weeks
Trial: 16216469
Drug: Ceftriaxone (CRO)
DrugBank: Ceftriaxone (DB01212)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (CRO) 100mg/kg once daily
Trial: 2108852
Drug: Aspirin with
RxNorm normalized name: Bayer Aspirin with Calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin with thrombolytic therapy
Trial: 16981054
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy alone
Trial: 30606246
Drug: Intramuscular oxytocin/ergometrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular oxytocin/ergometrine
Trial: 30606246
Drug: Intramuscular carbetocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular carbetocin
Trial: 22924356
Drug: Articaine 4%
RxNorm normalized name: ARTICAINE 4%/EPI 1:200000 INJ CART 1.7ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Articaine 4% with 1:100 000 adrenaline delivered via Buccal Infiltration (BI)
Trial: 19622592
Drug: Corticosteroid eyedrops
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid eyedrops (CS), administered six times daily during docetaxel administration
Trial: 19622592
Drug: Artificial tears
RxNorm normalized name: Artificial Tears
DrugBank: Polyethylene glycol 400 (DB11077)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial tears (AT), administered six times daily during docetaxel administration
Trial: 18068062
Drug: Air group
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air group (n = 26) - distal cuff inflated with 2 mL of air
Trial: 18068062
Drug: Saline group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline group (n = 26) - distal cuff inflated with 1.2 mL of saline
Trial: 1085738
Drug: Flufenamic acid
RxNorm normalized name: Flufenamic acid
DrugBank: Flufenamic acid (DB02266)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flufenamic acid ointment (Mobilisin)
Trial: 21878747
Drug: Functional electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Functional electrical therapy
Trial: 19332192
Drug: Antiplatelet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet therapy (specifics not provided)
Trial: 17130515
Drug: Chemotherapy-induced amenorrhea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy-induced amenorrhea
Trial: 10551494
Drug: E2F-decoy treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2F-decoy treatment
Trial: 10551494
Drug: Scrambled-oligodeoxynucleotide treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scrambled-oligodeoxynucleotide treatment
Trial: 8728041
Drug: Home total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home total parenteral nutrition (TPN; n = 16)
Trial: 1653362
Drug: CPT-11 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT-11 at weekly doses of 100 mg/m2
Trial: 1653362
Drug: CPT-11 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT-11 at weekly doses ranging from 50 to 150 mg/m2
Trial: 1653362
Drug: CPT-11 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT-11 at weekly doses
Trial: 6218370
Drug: CI2MDP 1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CI2MDP 1600 mg/d
Trial: 30846304
Drug: l-isoproterenol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-isoproterenol (10 μg/kg/h)
Trial: 30846304
Drug: salbutamol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: salbutamol (500 μg/kg/h)
Trial: 11236045
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml sucrose 24% w/v
Trial: 9593779
Drug: Enteral feeding
RxNorm normalized name: enteral feeding dispenser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral feeding plus exogenous insulin (200 pmol/h = 28 U/h) with extra glucose as needed (I+G)
Trial: 8534671
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg daily simvastatin
Trial: 8534671
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg daily simvastatin
Trial: 21782470
Drug: Unguided injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unguided injection
Trial: 30012233
Drug: Waiting list
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waiting list (treatment as usual)
Trial: 16546598
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate lotion 0.05% applied once daily for 4 weeks
Trial: 16546598
Drug: Placebo lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo lotion applied once daily for 4 weeks
Trial: 12778391
Drug: Standard or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard or high-dose cisplatin with etoposide and bleomycin
Trial: 12778391
Drug: Cisplatin dose
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin dose comparison
Trial: 8103526
Drug: S-timolol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-timolol (0.5 mg, 1 mg)
Trial: 8103526
Drug: R-timolol (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-timolol (3 mg, 10 mg)
Trial: 8103526
Drug: S-timolol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-timolol (1 mg, 3 mg)
Trial: 8103526
Drug: R-timolol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-timolol (25 mg, 75 mg)
Trial: 29724663
Drug: High-dose venlafaxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose venlafaxine with supportive management for 10 weeks
Trial: 15728057
Drug: Morphine (M-large)
RxNorm normalized name: morphine sulfate Extended Release Oral Capsule [M-Eslon]
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine (M-large) 0.43 mg/kg
Trial: 16368813
Drug: Morphine (M-small)
RxNorm normalized name: morphine sulfate Extended Release Oral Capsule [M-Eslon]
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine (M-small) 0.11 mg/kg
Trial: 12856052
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with mebendazole and levamisole
Trial: 31030379
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (660 nm, 100 mW, 2 J, 66.66 J/cm2, 3.3 W/cm2, 20 s of irradiation, punctual, and continuous mode)
Trial: 27220593
Drug: Pulmonary artery
RxNorm normalized name: Pulmonary artery blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmonary artery pressure-guided management (treatment group)
Trial: 27220593
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (symptoms and daily weights alone)
Trial: 16192511
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL anesthetic solution
Trial: 16192511
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (3 mL and 5 mL)
Trial: 4065432
Drug: Poor metabolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Poor metabolic control (median blood glucose 16.3 mmol/L)
Trial: 27281084
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone 5 mg
Trial: 8937760
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (desogestrel+ethinyloestradiol)
Trial: 8937760
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (levonorgestrel and ethinyloestradiol)
Trial: 3096681
Drug: Diazepam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (20 mg) + Methadone (150% of maintenance dose)
Trial: 3096681
Drug: Diazepam (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (40 mg) + Methadone (150% of maintenance dose)
Trial: 3096681
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + Methadone (100% of maintenance dose)
Trial: 29222891
Drug: Glucose (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (50 g/278 mL, p.o.) 2 h before anaesthesia induction
Trial: 27219115
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (once daily for 5 consecutive days starting on postoperative day 1, at 16 acupoints)
Trial: 27219115
Drug: Nonacupuncture (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonacupuncture (no treatment)
Trial: 25481809
Drug: Various OA
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various OA treatments (pharmacological and non-pharmacological)
Trial: 25481809
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy for knee OA
Trial: 25481809
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy for hip OA
Trial: 18025524
Drug: Peptidic erythropoiesis
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peptidic erythropoiesis receptor agonist at doses of 0.025, 0.05, and 0.1 mg/kg
Trial: 18025524
Drug: Peptidic erythropoiesis
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peptidic erythropoiesis receptor agonist
Trial: 9460311
Drug: Expectant management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Expectant management followed by induction with prostaglandin E2 gel
Trial: 3317352
Drug: 20 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms dose per injection
Trial: 27283332
Drug: Tapering csDMARDs
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tapering csDMARDs
Trial: 27283332
Drug: Tapering bDMARDs
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tapering bDMARDs
Trial: 19186857
Drug: Conventional root
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional root canal therapy (conventional therapy group)
Trial: 6782606
Drug: Secobarbital 1.47
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secobarbital 1.47 mg/kg
Trial: 6782606
Drug: Secobarbital 2.94
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secobarbital 2.94 mg/kg
Trial: 15530692
Drug: Connaught high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Connaught high titer vaccine (CN)
Trial: 12578106
Drug: Rocuronium administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium administered within 1‐15 seconds
Trial: 12578106
Drug: Rocuronium administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium administered within 30‐60 seconds
Trial: 26542030
Drug: Any treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any treatment (including chemotherapy, surgery, or radiotherapy)
Trial: 26542030
Drug: Local treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local treatment (surgery and/or radiotherapy)
Trial: 22925988
Drug: Amlodipine besylate
RxNorm normalized name: Amlodipine Besylate
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate 5 to 10 mg once daily
Trial: 22925988
Drug: S(‐)‐amlodipine nicotinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S(‐)‐amlodipine nicotinate 2.5 to 5 mg once daily
Trial: 12743773
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with lansoprazole (LPZ), amoxicillin (AMPC), and clarithromycin (CAM) for 7 days
Trial: 2753406
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g lactulose (L) with 20 mg metoclopramide (M)
Trial: 16000666
Drug: Bioabsorbable poly-l-lactic
RxNorm normalized name: L-Lactic acid
DrugBank: L-Lactic acid (DB14475)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bioabsorbable poly-l-lactic acid screws
Trial: 2294875
Drug: Quantitative fluorometry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quantitative fluorometry with intravenous fluorescein administration before amputation
Trial: 26871828
Drug: Clinical medicine-unrelated
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical medicine-unrelated topics
Trial: 26871828
Drug: Clinical medicine-related
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical medicine-related topics
Trial: 25015649
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (Se) during radiation therapy
Trial: 17939262
Drug: Levofloxacin 500
RxNorm normalized name: levofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 500 mg IV q24h followed by 500 mg orally q24h
Trial: 17939262
Drug: Amoxicillin/clavulanate 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate 500 mg/100 mg IV q8h with oral clarithromycin 500 mg q12h, then oral amoxicillin/clavulanate 250 mg/125 mg q8h with oral clarithromycin 500 mg q12h
Trial: 11973187
Drug: Acetaminophen 2000
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 2000 mg and Celecoxib 200 mg
Trial: 1745622
Drug: Acetaminophen 2000
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 2000 mg
Trial: 11973187
Drug: Placebo (Vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (Vitamin C, 500 mg)
Trial: 7859695
Drug: Spaghetti without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spaghetti without paracetamol
Trial: 2808056
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (prostate vs. prostate and pelvic lymph nodes)
Trial: 1020682
Drug: Oral dexetimide
RxNorm normalized name: dexetimide
DrugBank: Dexetimide (DB08997)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexetimide (0.5 to 1.5 mg daily)
Trial: 1020682
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment with antiparkinsonian agents)
Trial: 27847124
Drug: Passive robotic‐assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passive robotic‐assisted hand motion using the Gloreha device, twice a day for 2 weeks
Trial: 25890874
Drug: Vitamins E
RxNorm normalized name: Multiple Vitamins Essentials
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamins E (α‐[600 mg RRR‐α‐tocopherol, αT] and γ‐[600 mg of RRR‐γT]) and C (1000 mg ascorbic acid, AA)
Trial: 18971537
Drug: Calcium Channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium Channel Blocker (CCB)
Trial: 24360178
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II Receptor Antagonist (ARB)
Trial: 21900784
Drug: Rabeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (20 mg daily)
Trial: 3350281
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg daily)
Trial: 19912686
Drug: Lamivudine (LMV)
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lamivudine (LMV) 100 mg per day
Trial: 6861770
Drug: Propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 80 mg b.i.d.
Trial: 28802777
Drug: LIA with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LIA with liposomal bupivacaine (LB) 266 mg/20 mL (admixed with bupivacaine HCl 0.5%, 20 mL)
Trial: 28802777
Drug: LIA with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LIA with bupivacaine HCl 0.5%, 20 mL
Trial: 8864793
Drug: L-arginine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (30 g, 150 ml, 15 min)
Trial: 8864793
Drug: Placebo (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (150 ml NaCl)
Trial: 8864793
Drug: L-arginine (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (in PPH patients)
Trial: 27012596
Drug: Rivastigmine Patch
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine Patch (9.5 mg/24 h)